Drug-eluting stent thrombosis: Results from a pooled analysis including 10 randomized studies

Journal of the American College of Cardiology

Volumn 45, Issue 6, 2005, Pages 954-959

  Moreno, Raúl ^a   Fernández, Cristina ^a   Hernández, Rosana ^a   Alfonso, Fernando ^a   Angiolillo, Dominick J ^a   Sabaté, Manel ^a   Escaned, Javier ^a   Bañuelos, Camino ^a   Fernández Ortiz, Antonio ^a   MacAya, Carlos ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; PACLITAXEL; RAPAMYCIN;

CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; SAMPLE SIZE; STATISTICAL SIGNIFICANCE; THROMBOSIS;

EID: 20044388113     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.11.065     Document Type: Article

References (26)

1. M.C. Morice, P.W. Serruys, J.E. Sousa A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N Engl J Med 346 2002 1773 1780
2. J.W. Moses, M.B. Leon, J.J. Popma SIRIUS Investigators Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323
3. J. Schofer, M. Schluter, A.H. Gershlick, W. Wijns, E. Garcia, E. Schampaert, G. Breithardt E-SIRIUS Investigators Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS) Lancet 362 2003 1093 1099
4. E. Schampaert, E.A. Cohen, M. Schluter C-SIRIUS Investigators The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS) J Am Coll Cardiol 43 2004 1110 1115
5. M.K. Hong, G.S. Mintz, C.W. Lee ASian Paclitaxel-Eluting Stent Clinical Trial Investigators Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries: a serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT) Circulation 107 2003 517 520
6. A. Gershlick, I. De Scheerder, B. Chevalier Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial Circulation 109 2004 487 493
7. E. Grube, S. Silber, K.E. Hauptmann TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions Circulation 107 2003 38 42
8. A. Colombo, J. Drzewiecki, A. Banning TAXUS II Study Group Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions Circulation 108 2003 788 794
9. G.W. Stone, S.G. Ellis, D.A. Cox TAXUS-IV Investigators A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 2004 221 231
10. A. Lansky, R.A. Costa, G.S. Mintz for the DELIVER Clinical Trial Investigators Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions Angiographic follow-up of the DELIVER Clinical TrialCirculation 109 2004 1948 1954
11. R. Moreno, R. Hernandez, M. Sabate, D.J. Angiolillo, C. Macaya Situacion actual del tratamiento con stents coronarios recubiertos de fármacos antiproliferativos (I) Cardiol Pract (Barc) 12 2003 31 41
12. D.E. Cutlip, D.S. Baim, K.K.L. Ho Stent thrombosis in the modern era A pooled analysis of multicenter coronary stent clinical trials Circulation 103 2001 1967 1971
13. D. Moher, D.J. Cook, S. Eastwood, I. Olkin, D. Rennie, D.F. Stroup Improving the quality of reports of meta-analysis of randomised controlled trials: the QUOROM statement Lancet 354 1999 1896 1900
14. J.L. Orford, R. Lennon, S. Melby Frequency and correlates of coronary stent thrombosis in the modern era: analysis of a single center registry J Am Coll Cardiol 40 2002 1567 1572
15. R. Virmani, A. Farb, F.D. Kolodgie Histopathologic alterations after endovascular radiation and antiproliferative stents: similarities and differences Herz 27 2002 1 6
16. A. Babinska, M.S. Markell, M.O. Salifu, M. Akoad, Y.H. Ehrlich, E. Kornecki Enhancement of human platelet aggregation and secretion induced by rapamycin Nephrol Dial Transplant 13 1998 3153 3159
17. P.A. Lemos, C. Lee, M. Degertekin Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes Insight from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) Registry J Am Coll Cardiol 41 2003 2093 2099
18. V. Pasceri, A. Granatelli, C. Pristipino, F. Pelliccia, B. Pironi, G. Richichi High-risk of thrombosis of Cypher stent in patients not taking ticlopidine or clopidogrel (abstr) Am J Cardiol 92 2003 91L
19. R. Virmani, G. Guagliumi, A. Farb Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent Should we be cautious? Circulation 109 2004 r38 r42
20. P.W. Serruys Insights from the intravascular ultrasound analysis in TAXUS-II. Transcatheter and Cardiovascular Interventions 2003 http://www.tctmd.com/display/expert/pdf/83343/serruys2-DESS-taxus.pdf Accessed October 29, 2004
21. A. Chieffo, E. Bonizzoni, D. Orlic Intraprocedural stent thrombosis during implantation of sirolimus-eluting stents Circulation 109 2004 2732 2736
22. G. Stankovic, D. Orlic, A. Chieffo Predictors of creatinine kinase MB enzyme elevation after percutaneous coronary intervention using sirolimus-eluting stents (abstr) Am J Cardiol 92 2003 182L
23. R. Moreno, C. Fernandez, F. Alfonso Coronary stenting versus balloon angioplasty in small vessels A meta-analysis of eleven randomized studies J Am Coll Cardiol 43 2004 1964 1972
24. J.E. Sousa, M.A. Costa, A. Sousa Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries Circulation 107 2003 381 383
25. SIRIUS Trial Investigators D.R. Holmes Two-year follow-up of the SIRIUS study: a randomised study with the sirolimus-eluting Bx Velocity in the treatment of patients with de-novo native coronary artery lesions http://www.tctmd.com/display/expert/pdf/95156/Holmes-DESS.pdf Accessed October 29, 2004
26. F. Alfonso, A. Suarez, D.L. Angiolillo Findings of intravascular ultrasound during acute stent thrombosis Heart 90 2004 1455 1459